References
- Guidance for Industry: Q8 (R2) Pharmaceutical Development. ICH Harmonized Tripartite Guideline, Step 4, August 2009.
- Pifferi G, Santoro P, Pedrani M. Quality and functionality of excipients. Farmaco 1999;54:1–14.
- Moreton RC. Functionality and performance of excipient in a quality-by-design world: Part VIII: excipient specification. Am Pharm Rev 2009;12:48–51.
- Siepmann J, Peppas NA. Modelling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2011;48:139–157.
- European Pharmacopeia. 8th ed. Strasbourg, France: Council of Europe; 2014.
- Devjak Novak S, Kuhelj V, Vrečer F, Baumgartner S. The influence of HPMC viscosity as FRC parameter on the release of low soluble drug from hydrophilic matrix tablets. Pharm Dev Technol 2013;18:343–347.
- Gao P, Skoug JW, Nixon PR, et al. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release. J Pharm Sci 1996;85:732–740.
- Ju TR, Nixon PR, Patel MV. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J Pharm Sci 1995;84:1455–1463.
- Kavanagh N, Corrigan OI. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices—influence of agitation rate and dissolution medium composition. Int J Pharm 2004;279:141–152.
- Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr 1984;5:1–9.
- Larsson M, Viridén A, Stading M, Larsson A. The influence of HPMC substitution pattern on solid-state properties. Carbohydr Polym 2010;82:1074–1081.
- Caraballo I. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories. Expert Opin Drug Deliv 2010;7:1291–1301.
- Heng PWS, Chan LW, Easterbrook MG, Li X. Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J Control Release 2001;76:39–49.
- Mitchell K, Ford JL, Armstrong DJ, et al. The influence of the particle size of hydroxypropylmethylcellulose K15M on its hydration and performance in matrix tablets. Int J Pharm 1993;100:175–179.
- Dahl TC, Calderwood T, Bormeth A, et al. Influence of physico-chemical properties of hydroxypropyl methylcellulose on naproxen release from sustained release matrix tablets. J Control Release 1990;14:1–10.
- Viriden A, Wittgren B, Larsson A. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Eur J Pharm Sci 2009;36:297–309.
- Cabelka T, Faham A, Bernthal H, Rajabi-Siahboomi A. Application of Quality by Design (QbD) principles to the formulation of a hydrophilic matrix tablet of a high dose/high solubility drug. Los Angeles, CA: AAPS Annual Meeting and Exposition; 2009.
- Deng H, Vass S, Tiwari S, et al. Application of Quality by Design (QbD) principles to METHOCEL™ K15M formulations of extended release theophylline matrix tablets. National Harbor, MD: CRS Annual Meeting and Exposition; 2011.
- Deng H, Vass S, Tiwari S, et al. Application of Quality by Design (QbD) principles to the formulation of extended release propranolol hydrochloride hydrophilic matrix tablets. New Orleans, LA: AAPS Annual Meeting and Exposition; 2010.